Skip to content
All about casino & gambling.

Overview of Bayer's Global Subsidiaries: A Detailed Look at Its Owned Companies

Global conglomerate Bayer, a dominant force, specializes in life science sectors such as health care and agriculture. A colossus in the pharmaceutical industry.

,   and  Administrator
4 min read
"An Examination of Bayer's Corporate Empire: Insight into Its International Affiliates"
"An Examination of Bayer's Corporate Empire: Insight into Its International Affiliates"

Overview of Bayer's Global Subsidiaries: A Detailed Look at Its Owned Companies

Bayer, a global leader in the pharmaceutical, healthcare, and agricultural sectors, has announced impressive financial results for the recent quarter. The company's group sales have seen an increase of 8.7 percent, adjusting for foreign exchange and portfolio changes, to 50.739 billion euros.

The agricultural business, Crop Science, experienced a hefty increase in sales by 25.8 percent. This growth was driven by both volume and price increases, with the division's exceptional performance contributing significantly to the overall earnings.

Bayer's sustainability strategy is an integral part of their corporate identity. The company is committed to inclusive growth and responsible resource use, with a focus on environmental, economic, and social benefits. They aim to be carbon-neutral by 2030 and are partnering with organizations like Manufacture 2030 to reduce CO2 emissions.

The company's portfolio includes a variety of well-known brands. In the pharmaceutical sector, Bayer HealthCare Pharmaceuticals and Bayer Schering Pharma AG are primary subsidiaries, focusing on prescription drugs like cancer drug Nexavar, multiple sclerosis drug betaferon/betaseron, and blood-clotting drug Kogenate. Innovation efforts include drugs like Nubeqa™ and Kerendia™, supporting a robust R&D pipeline.

In the consumer health sector, Bayer Consumer Care manages the over-the-counter (OTC) medicines portfolio. Key subsidiaries include Bayer Consumer Care and the recent acquisition of Merck & Co's consumer health unit. Products in this sector include Bayer Aspirin, Aleve, Redoxon, Berocca, and skincare brands like Bepanthen.

Bayer CropScience Limited, particularly in India, is the key subsidiary in the agricultural sector. The company holds a leading position in seeds and traits, crop protection, and digital-enabled agricultural solutions. Innovation efforts include products like the Preceon™ Smart Corn System and Vyconic™ soybeans, aiming for significant sales growth and high EBITDA margins by 2029.

Previously part of Bayer HealthCare, Animal Health is now an independent business unit within Bayer. The company remains focused on animal health products.

To summarise, Bayer's key subsidiaries and units are as follows:

| Sector | Key Bayer Subsidiaries / Units | Key Details / Products | |------------------|-----------------------------------------------------------------|--------------------------------------------------------------------| | Pharmaceuticals | Bayer HealthCare Pharmaceuticals, Bayer Schering Pharma AG | Drugs: Nexavar, betaferon/betaseron, Kogenate, Nubeqa™, Kerendia™ | | Consumer Health | Bayer Consumer Care, Merck & Co's Consumer Health Unit, Dihon Pharmaceutical (China) | OTC: Bayer Aspirin, Aleve, Redoxon, Berocca, Bepanthen | | Crop Science | Bayer CropScience Limited (India) | Seeds & traits, crop protection, digital/agriculture innovation | | Animal Health | Bayer Animal Health (now a standalone business unit) | Focused on animal health products |

The company's global operations are supported by manufacturing facilities situated in numerous countries, each playing a crucial role in the company's international operations.

Bayer remains optimistic with an outlook being raised following a solid second quarter in the previous fiscal year. The company has confirmed its outlook for 2023, expecting strong growth despite a third quarter that performed below the prior year. With the proposition for a substantial dividend increase, Bayer asserts their confidence in sustaining growth and rewarding shareholders.

The company is also investing in sustainable health products, part of their broader commitment to sustainability. Bayer sees sustainability as a threefold notion: environmental, economic, and social, with a commitment to equitable benefits across communities.

In addition, Bayer is preparing for a new chapter in leadership, with current CEO Werner Baumann set to retire and Bill Anderson appointed as the successor.

The company is also making efforts to reduce environmental impacts in their operations and supply chain, with more environmentally friendly crop protection practices.

Key competitors in the pharmaceutical industry include AstraZeneca, GSK, Johnson & Johnson, Novartis, Pfizer, and Roche.

[1] Bayer AG (2021). Annual Report 2020. Retrieved from https://www.bayer.com/en/annual-report-2020.aspx

[2] Bayer AG (2021). Sustainability Report 2020. Retrieved from https://www.bayer.com/en/sustainability/reports/sustainability-report-2020.aspx

[3] Bayer AG (2021). Bayer Crop Science. Retrieved from https://www.bayer.com/en/crop-science.aspx

[4] Bayer AG (2021). Bayer Consumer Health. Retrieved from https://www.bayer.com/en/consumer-health.aspx

[5] Bayer AG (2021). Bayer Monsanto. Retrieved from https://www.bayer.com/en/crop-science/monsanto.aspx

  1. Bayer's growth in the financial sector has been impressive, with a 8.7% increase in sales, as reported in their recent quarterly results.
  2. The company's focus on sustainability is reflected in their strategy of inclusive growth and responsible resource use.
  3. Bayer's goal is to be carbon-neutral by 2030, with partnerships with organizations like Manufacture 2030 aimed at reducing CO2 emissions.
  4. In the pharmaceutical sector, Bayer's key subsidiaries include Bayer HealthCare Pharmaceuticals and Bayer Schering Pharma AG, which focus on drugs like Nexavar, betaferon/betaseron, and Kogenate.
  5. Innovation efforts in the pharmaceutical sector include drugs like Nubeqa™ and Kerendia™, which support a robust R&D pipeline.
  6. In the consumer health sector, Bayer's key subsidiaries include Bayer Consumer Care and the recent acquisition of Merck & Co's consumer health unit.
  7. Key products in the consumer health sector include Bayer Aspirin, Aleve, Redoxon, Berocca, and skincare brands like Bepanthen.
  8. In the agricultural sector, Bayer CropScience Limited (India) holds a leading position in seeds and traits, crop protection, and digital-enabled agricultural solutions.
  9. The animal health sector is now an independent business unit within Bayer, with a focus on animal health products.
  10. Bayer is planning to reduce environmental impacts in their operations and supply chain, with more environmentally friendly crop protection practices.
  11. Key competitors in the pharmaceutical industry include AstraZeneca, GSK, Johnson & Johnson, Novartis, Pfizer, Roche, and other companies in the fields of technology, artificial intelligence, general news, sports, weather, fashion-and-beauty, food-and-drink, home-and-garden, education-and-self-development, travel, casino-and-gambling, and personal-finance.

Read also:

    Related

    Latest